Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sevuparin sodium

EU orphan designation number: EU/3/15/1433   
Active ingredient: Sevuparin sodium
Indication: Treatment of sickle cell disease
Sponsor: Modus Therapeutics AB
Sankt Eriksgatan 117, SE-113 43 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/210/14 (2015)933 of 12/02/2015
13/03/2017 Change of name and/or address of sponsor